These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6408438)

  • 21. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin treatment for the early 80s: facts and questions about old and new insulins and their usage.
    Galloway JA
    Diabetes Care; 1980; 3(5):615-22. PubMed ID: 7002515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of the value of Rapitard insulin].
    Fedder G; Pompen AW
    Ned Tijdschr Geneeskd; 1969 Feb; 113(6):239-42. PubMed ID: 4889873
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.
    Ward EA; Ward GM; Turner RC
    Br Med J (Clin Res Ed); 1981 Jul; 283(6286):278. PubMed ID: 6788293
    [No Abstract]   [Full Text] [Related]  

  • 25. Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.
    Hollander PA; Krasner A; Klioze S; Schwartz P; Duggan W
    Diabetes Care; 2007 Oct; 30(10):2508-10. PubMed ID: 17536080
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Testing of ketoprofen for interaction with oral antidiabetics. A double-blind controlled clinical crossover study].
    Voigt U; Klassen E
    Med Welt; 1982 Nov; 33(45):1592-3. PubMed ID: 6757642
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lack of effect of guar gum (Slocose) on blood glucose in insulin-treated diabetes mellitus].
    Krarup T; Sestoft L
    Ugeskr Laeger; 1980 Nov; 142(45):2979-81. PubMed ID: 7008302
    [No Abstract]   [Full Text] [Related]  

  • 30. [Insulin treatment of diabetes mellitus (author's transl)].
    Fankhauser S
    Schweiz Rundsch Med Prax; 1977 Jul; 66(30):935-41. PubMed ID: 896663
    [No Abstract]   [Full Text] [Related]  

  • 31. An appraisal of the role of biosynthetic human insulin in the future treatment of diabetes mellitus.
    Gerich JE
    Diabetes Care; 1981; 4(2):262-4. PubMed ID: 7011743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diacylglycerol-induced improvement of whole-body insulin sensitivity in type 2 diabetes mellitus: a long-term randomized, double-blind controlled study.
    Li D; Xu T; Takase H; Tokimitsu I; Zhang P; Wang Q; Yu X; Zhang A
    Clin Nutr; 2008 Apr; 27(2):203-11. PubMed ID: 18314230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of human insulin in the therapy of diabetes mellitus.
    Karam JH
    Diabetes Care; 1983; 6 Suppl 1():1-2. PubMed ID: 6343030
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistant diabetes treated with sulfated insulin.
    Menczel J; Levy M; Bentwich Z
    Isr J Med Sci; 1966; 2(6):764-8. PubMed ID: 5956693
    [No Abstract]   [Full Text] [Related]  

  • 36. [Human insulin--therapeutic progress?].
    Sonnenberg GE; Berger M
    Dtsch Med Wochenschr; 1983 Jun; 108(24):927-9. PubMed ID: 6343053
    [No Abstract]   [Full Text] [Related]  

  • 37. [Indications and limitations of swine insulin therapy].
    Journ Annu Diabetol Hotel Dieu; 1969; 10():423-6. PubMed ID: 5394055
    [No Abstract]   [Full Text] [Related]  

  • 38. [Human insulin: therapeutic progress?].
    Slama G; Tchobroutsky G
    Ann Med Interne (Paris); 1985; 136(2):89-90. PubMed ID: 3907450
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative in vivo study of the activity of biosynthetic human insulin and bovine insulin in healthy humans].
    Bruno A; Cavallo-Perin P; Dall'Omo AM; Ozzello A; Pagano G
    Minerva Endocrinol; 1984; 9(3):355-8. PubMed ID: 6398401
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biosynthetic human insulin in comparison with conventional intermediary insulin from cattle].
    Etti H; Bamberg E; Enzmann F; Haupt E
    Med Welt; 1983 Sep; 34(37):1007-9. PubMed ID: 6355748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.